Actemra (Roche) is an immuno-suppressant to treat moderate to severe rheumatoid arthritis. Launch concept using 'Articluated' and active model was designed to reflect freedom from the effects of rheumatoid arthritis (RA) (Agency: LLNS) Interleukin 6 (IL-6) is a pleiotropic cytokine with a pivotal role in the pathophysiology of rheumatoid arthritis (RA).
Advair (GSK). Art direction for patient profile page from vis-aid for asthma treatment (Agency: Grey Healthcare)
Bayer AG - Campaigns to HCPs promoting preventative benefits of aspirin (Agency: Harrison & Star)
Forest Laboratories. Unbranded campaign for launch of new beta-blocker treatment, Nebivolol, for hypertension (Agency: Grey Healthcare)
Forest Laboratories. Unbranded campaign concept to launch, Nebivolol, a new beta-blocker treatment for hypertension (Agency: Grey Healthcare)
Myviva (JAZZ Pharmaceuticals). Unbranded HCP mailer using patient pain scale (smiley face chart) that focuses on symptoms of fibromyalgia and Xyrem. (Agency: OgilvyInteractive)
Xyrem was found to treat patients suffering from fibromyalgia. Second page from Myviva (JAZZ Pharmaceuticals). Detail from unbranded mailer continued. (Agency: OgilvyInteractive)
Page 3 of Myviva Unbranded Mailer - HCP
Final page of Myviva Unbranded Mailer - description
Valcyte (Roche-Genentech). Adult kidney transplant. Payer value proposition flashcard included in launch treatment for antiviral medication used to treat cytomegalovirus infections. (Agency: IOMedia)
Valcyte (Roche-Genentec). Adult kidney transplant. Flashcard included in launch treatment for antiviral medication used to treat cytomegalovirus infections. (Agency: IOMedia)
Grazax (Schering-Plough). Initial campaign for launch of a sublingual antigen-focused hay fever and blue grass allergy treatment (Agency: LLNS)
Logo designs/names for Movectro
Herceptin. Concept for launch of HER2-targeted breast cancer therapy. (Agency: Flashpoint Medica)
Herceptin. Concept for launch of HER2-targeted therapy for breast cancer. (Agency: Flashpoint Medica)
Xifaxan (rifaximin) tablets contain rifaximin, a non-aminoglycoside semi-synthentic antibiotic indicated in the treatment of hepatic encephalopothy. This banner campaign was used in the launch of the new indication
HCP Campaigns

Fibromyalgia is a chronic disorder characterized by soft-tissue painful response to pressure. It is often misdiagnosed by HCPs. JAZZ Pharmaceutical provided mailers aimed at HCPs for Myviva (aka Xyrem) to help diagnose the disease

View Website
Jon Medwick
Integrated Copywriter/ Healthcare New York, NY